Millennium Management’s Senti Biosciences Holdings SNTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-40
Closed -$5.03K – 6486
2024
Q1
$5.03K Sell
40
-4
-9% -$590 ﹤0.01% 6006
2023
Q4
$9.5K Buy
+44
New +$5.66K ﹤0.01% 5747
2023
Q1
– Sell
-69
Closed -$32K – 6826
2022
Q4
$32K Sell
69
-63
-48% -$50.7K ﹤0.01% 5914
2022
Q3
$95K Buy
132
+22
+20% +$14.3K ﹤0.01% 5988
2022
Q2
$71K Sell
110
-2,453
-96% -$6.5M ﹤0.01% 6058
2022
Q1
$8.35M Buy
2,563
+1,296
+102% +$4.22M ﹤0.01% 2352
2021
Q4
$4.12M Sell
1,267
-69
-5% -$227K ﹤0.01% 3102
2021
Q3
$4.38M Buy
1,336
+15
+1% +$48.8K ﹤0.01% 3015
2021
Q2
$4.33M Buy
+1,321
New +$4.35M ﹤0.01% 2944

Other funds holding SNTI

Millennium Management's SNTI Position: Q2 2024 in Review

Millennium Management sold out of Senti Biosciences Holdings (SNTI) in Q2 2024, closing a stake of 40 shares — an estimated $5.03K sold.

Millennium Management first reported a position in SNTI in Q2 2021 and held it in 9 quarters. The position peaked at $8.35M in Q1 2022. 20 funds tracked by Wall St. Rank hold SNTI as of Q2 2024.

  • Millennium Management reported no remaining Senti Biosciences Holdings position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 40 Senti Biosciences Holdings shares in Q2 2024, an estimated $5.03K.
  • Millennium Management first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 9 quarters.
  • Millennium Management's Senti Biosciences Holdings position peaked at $8.35M in Q1 2022.
  • 20 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.